|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.24 USD | +4.69% |
|
-3.20% | -24.96% |
| 06-10 | C4 Therapeutics Appoints Ron Cooper Board Chairman | MT |
| 06-10 | C4 Therapeutics, Inc. Announces Board and Committee Changes | CI |
C4 Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 28.36 million compared to USD 34.78 million a year ago. Basic loss per share from continuing operations was USD 0.41 compared to USD 0.71 a year ago.
Diluted loss per share from continuing operations was USD 0.41 compared to USD 0.71 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.96% | 292M | |
| +34.14% | 51.12B | |
| -6.54% | 39.4B | |
| +34.92% | 38.48B | |
| +12.62% | 26.36B | |
| -12.11% | 26.22B | |
| -13.43% | 20.96B | |
| +43.73% | 14.02B | |
| +31.81% | 12.49B | |
| -4.54% | 11.61B |
C4 THERAPEUTICS, INC. 
